The Latest Breaking News from NICE

Lyme disease: What are the symptoms and how can it be treated?

Lyme Disease UK has warned that the disease is on the rise in the UK

The Independent UK · Oct 9, 2024

Mounjaro will soon be available as a weight loss treatment on the NHS – here’s what that means for patients

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to proposals made by the National Institute for Health and Care Excellence (Nice). Previously, it was only available on the NHS for patients with diabetes.

The Conversation · Oct 8, 2024

Weight loss drugs shouldn’t create ‘dependency culture’, says Health Secretary

Mr Sweeting said it was in “everyone’s interest to play their part” and avoid overloading the health system.

Evening Standard · Oct 6, 2024

Ten of the best-value deals from this summer’s transfer window

Close to £5bn was spent by Europe’s top five men’s leagues – but which players may prove to be worth the fees paid?

The Guardian - UK · Sep 4, 2024

Europa League and Conference League draw: As they happened

The Europa League and Conference League have drawn some fantastic fixtures for the league stage of the competition

FourFourTwo · Aug 30, 2024

Every footballer to have received a perfect 10 from L’Equipe: featuring Lionel Messi, Ademola Lookman and Neymar

Only 15 players in football history have achieved a perfect 10/10 match rating from the prestigious publication.

FourFourTwo · Aug 25, 2024

UK drug regulator approves Alzheimer's drug but government likely won't pay for it

Britain’s drug regulator has authorized the Alzheimer’s drug Leqembi, saying that it’s the first medicine to show some impact in slowing progression of the neurodegenerative disease

The Independent UK · Aug 22, 2024

What you need to know about lecanemab – the Alzheimer’s drug rejected for NHS use

The drug has been developed by Eisai, a Japanese pharmaceutical company, and is sold under the brand name Leqembi

The Independent UK · Aug 22, 2024

What is Lecanemab and who makes it? Alzheimer’s drug gets approval but will not be available on the NHS

NICE says drug is not cost effective and shares fears of side effects

Evening Standard · Aug 22, 2024

First drug to slow Alzheimer’s progression will not be made available on the NHS

The spending watchdog has recommended that a drug shown to slow the progression of Alzheimer’s disease should not be rolled out on the NHS.

The Independent UK · Aug 22, 2024